We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
-6.86%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$166M
AUM Growth
+$8.35M
Cap. Flow
+$27.8M
Cap. Flow %
16.81%
Top 10 Hldgs %
40.91%
Holding
125
New
39
Increased
43
Reduced
18
Closed
15

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$4.42M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$3.73M
3
TGNA
TEGNA Inc
TGNA
+$3.12M
4
BCYC
Bicycle Therapeutics
BCYC
+$2.8M
5
TWTR
Twitter, Inc.
TWTR
+$2.75M

Top Sells

Rank Stock Value
1
PBCT
People's United Financial Inc
PBCT
+$3.92M
2
FIS icon
Fidelity National Information Services
FIS
+$3.85M
3
CERN
Cerner Corp
CERN
+$3.49M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$1.5M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$979K

Sector Composition

Rank Sector Weight
1 Healthcare 46.47%
2 Technology 22.39%
3 Financials 16.85%
4 Communication Services 4.29%
5 Consumer Discretionary 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOAH
101
Noah Holdings
NOAH
$605M
$225K 0.14%
+11,116
New +$207K
SCPL
102
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$222K 0.13%
+15,922
New +$212K
TEAM icon
103
Atlassian
TEAM
$38.5B
$221K 0.13%
+1,178
New +$251K
DDOG icon
104
Datadog
DDOG
$93.6B
$220K 0.13%
+2,310
New +$254K
WRBY icon
105
Warby Parker
WRBY
$3.26B
$220K 0.13%
+19,550
New +$393K
XPO icon
106
XPO
XPO
$23.5B
$220K 0.13%
+7,678
New +$244K
CIXX
107
DELISTED
CI Financial Corp.
CIXX
$220K 0.13%
+20,658
New +$261K
KSS icon
108
Kohl's
KSS
$2.16B
$218K 0.13%
+6,106
New +$299K
CHTR icon
109
Charter Communications
CHTR
$18.3B
$211K 0.13%
+450
New +$219K
IQ icon
110
iQIYI
IQ
$1.31B
$157K 0.09%
+37,518
New +$151K
CCCC icon
111
C4 Therapeutics
CCCC
$400M
– –
-34,760
Closed -$843K
FIS icon
112
Fidelity National Information Services
FIS
$21.9B
– –
-38,303
Closed -$3.85M
PRTA icon
113
Prothena Corp
PRTA
$468M
– –
-12,953
Closed -$474K
RCKT icon
114
Rocket Pharmaceuticals
RCKT
$397M
– –
-48,191
Closed -$764K
VERV
115
DELISTED
Verve Therapeutics
VERV
– –
-14,073
Closed -$321K
VRTX icon
116
Vertex Pharmaceuticals
VRTX
$133B
– –
-3,752
Closed -$979K
VTGN icon
117
VistaGen Therapeutics
VTGN
$11.7M
– –
-10,529
Closed -$392K
ONC
118
BeOne Medicines Ltd
ONC
$40.6B
– –
-2,002
Closed -$378K
GRTS
119
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
– –
-88,318
Closed -$364K
NGM
120
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-46,243
Closed -$705K
NVTA
121
DELISTED
Invitae Corporation
NVTA
– –
-75,472
Closed -$602K
DICE
122
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-48,960
Closed -$937K
CERN
123
DELISTED
Cerner Corp
CERN
– –
-37,300
Closed -$3.49M
PBCT
124
DELISTED
People's United Financial Inc
PBCT
– –
-196,100
Closed -$3.92M
BHVN
125
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-12,678
Closed -$1.5M
1 2 3 4
5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

HighVista Strategies's Q2 2022 Portfolio in Review

As of Q2 2022, HighVista Strategies held 125 positions worth $166M, up 5.3% from $157M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

HighVista Strategies deployed $27.8M of net new capital in Q2 2022, opening 39 new positions and adding to 43 existing holdings. Its largest new stake was iShares Russell 1000 Value ETF: 23,825 shares worth $3.45M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Protagonist Therapeutics, an estimated $551K trimmed.

  • HighVista Strategies's largest Q2 2022 buy was iShares Russell 1000 Value ETF: 23,825 shares worth $3.45M.
  • HighVista Strategies added most to Mastercard in Q2 2022, an estimated $4.42M increase.
  • HighVista Strategies's biggest Q2 2022 reduction was Protagonist Therapeutics, cutting an estimated $551K.
  • HighVista Strategies fully exited People's United Financial Inc in Q2 2022, selling an estimated $3.92M.
  • HighVista Strategies's ten largest holdings make up 41% of its $166M portfolio in Q2 2022.
  • HighVista Strategies opened 39 new positions and closed 15 in Q2 2022.
  • HighVista Strategies's portfolio value rose 5.3% quarter-over-quarter to $166M.

Based on HighVista Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.